Phase I study of tremelimumab (CP-675 206) plus PF-3512676 (CPG 7909) in patients with melanoma or advanced solid tumours (Q36896203)
Jump to navigation
Jump to search
scientific article published on 7 May 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I study of tremelimumab (CP-675 206) plus PF-3512676 (CPG 7909) in patients with melanoma or advanced solid tumours |
scientific article published on 7 May 2013 |
Statements
1 reference
Phase I study of tremelimumab (CP-675 206) plus PF-3512676 (CPG 7909) in patients with melanoma or advanced solid tumours (English)
1 reference
M Millward
1 reference
C Underhill
1 reference
S Lobb
1 reference
J McBurnie
1 reference
S J Meech
1 reference
J Gomez-Navarro
1 reference
M A Marshall
1 reference
B Huang
1 reference
C B Mather
1 reference
7 May 2013
1 reference
1 reference
1998-2004
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference